LYCA Conversion Disclosure
Venrock Healthcare Capital Partners Iii, L.p. · SEC Form 4 · Filed Oct 27, 2026
Conversion
Calculated transaction value
$0
Venrock Healthcare Capital Partners Iii, L.p. 10% owner
LYCA
Transaction date
Oct 26, 2026
Public filing date
Oct 27, 2026
Filing lag
Filed 1 day later
LYCA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series D Preferred Stock on Common Stock
- Quantity / price
- 4,408,091 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001231919-26-001503
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$37.65M
Buys / sales
6 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lycia Therapeutics, Inc. LYCA | Buy | Oct 27, 2026 | $833.84K |
| Lycia Therapeutics, Inc. LYCA | Buy | Oct 27, 2026 | $225.56K |
| Lycia Therapeutics, Inc. LYCA | Conversion | Oct 26, 2026 | Not reported |
| Lycia Therapeutics, Inc. LYCA Current | Conversion | Oct 26, 2026 | $0 |
| Lycia Therapeutics, Inc. LYCA | Conversion | Oct 26, 2026 | $0 |
| Lycia Therapeutics, Inc. LYCA | Buy | Oct 26, 2026 | $35M |
| Lycia Therapeutics, Inc. LYCA | Buy | Oct 26, 2026 | $222.8K |
| Lycia Therapeutics, Inc. LYCA | Buy | Oct 23, 2026 | $630.7K |
| Lycia Therapeutics, Inc. LYCA | Buy | Oct 23, 2026 | $740.98K |